Pricing Log in Create free account

Anavex Life Sciences Corp. (AVXL) vs Immunic, Inc. (IMUX)

Anavex Life Sciences Corp. and Immunic, Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Immunic, Inc. are of similar size ($102.9M and $99.9M). Across the 8 metrics below, Anavex Life Sciences Corp. leads on 5 and Immunic, Inc. on 3.

Valuation

Metric AVXL IMUX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.95 2.60 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.67 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (13.04%) (56.15%) (32.88%)
Free cash flow yield (27.48%) (26.55%) (23.13%)

Profitability

Metric AVXL IMUX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (12.80%) (138.17%) (51.96%)
Return on assets (11.70%) (101.15%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL IMUX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (3.85%) 38.00% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL IMUX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.62 5.05 4.97
Net debt to EBITDA 2.00 0.15 1.01

Dividend

Metric AVXL IMUX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AVXL IMUX Biotechnology median
Market cap 102.90m 99.88m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack